The FDA has closed the first quarter of 2017 with a spike in drug approvals and endorsements. Over the last few months, the FDA has endorsed 13 drugs and officially approved 12 new drugs. This pace of approval tops recent years which have wavered between 6 and 10 approvals in the first quarter. This pace may slowdown in coming months, however, as the agency already has round 20 pending applications for pharmaceuticals and biologics for the coming year. Read the full press release here.
